Novartis (NVS) Q4 Earnings & Sales Miss, Sandoz Review Ongoing

Novartis AG NVS reported disappointing fourth-quarter 2021 results as the Sandoz business continues to affect its performance.

Core earnings (excluding one-time charges) of $1.40 per share missed the Zacks Consensus Estimate of $1.44 but increased from $1.34 reported in the year-ago quarter.